- Joined
- Aug 2, 2013
- Messages
- 1,202
Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease
https://clinicaltrials.gov/ct2/show/study/NCT02048618?term=crohn's+disease&rank=125
-----------------------------------------------------------------------------
Preclinical characterization of GLPG0634, a selective inhibitor of JAK1, for the treatment of inflammatory diseases.
http://www.ncbi.nlm.nih.gov/pubmed/24006460
https://clinicaltrials.gov/ct2/show/study/NCT02048618?term=crohn's+disease&rank=125
-----------------------------------------------------------------------------
Preclinical characterization of GLPG0634, a selective inhibitor of JAK1, for the treatment of inflammatory diseases.
http://www.ncbi.nlm.nih.gov/pubmed/24006460
Last edited:
